|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
San Francisco,US
|
|
We are a fast-growing, pre-clinical-stage biopharmaceutical company developing tumor-specific T cell receptor (TCR) therapies. Our dynamic, international team sets out with the ambitious goal to revolutionize the TCR landscape using our unique and proprietary transgenic HuTCR mouse platform to produce fully human TCRs for the treatment of cancer. To achieve this ambitious goal, we have successfully completed Series A financing with top-tier investors in August 2020.
|
T-knife Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used T-knife Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact T-knife Therapeutics customer service number in your country click here to find.
Danielle Delorio is the CEO of T-knife Therapeutics. To contact Danielle Delorio email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.